Sarepta Therapeutics
SRPT
SRPT
402 hedge funds and large institutions have $10.1B invested in Sarepta Therapeutics in 2020 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 133 increasing their positions, 143 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
3.47% less ownership
Funds ownership: 94.78% → 91.31% (-3.5%)
13% less call options, than puts
Call options by funds: $327M | Put options by funds: $375M
15% less capital invested
Capital invested by funds: $11.9B → $10.1B (-$1.79B)
Holders
402
Holding in Top 10
7
Calls
$327M
Puts
$375M
Top Buyers
| 1 | +$284M | |
| 2 | +$282M | |
| 3 | +$46.7M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$38.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.2M |
Top Sellers
| 1 | -$347M | |
| 2 | -$208M | |
| 3 | -$68.3M | |
| 4 |
JP Morgan Chase
New York
|
-$63.8M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$54.5M |